Education Lab

Ace the Case: A 52-Year-Old Patient With Rheumatoid Arthritis Who Had an Inadequate Response to Methotrexate and a Tumor Necrosis Factor Inhibitor

This educational activity will utilize a case study to discuss the management of a 52-year-old patient with rheumatoid arthritis (RA) who had inadequate response to methotrexate and a tumor necrosis factor (TNF) inhibitor.

Case Presentation

Chief Complaint: Rheumatoid arthritis (RA) with worsening symptoms despite taking methotrexate and a tumor necrosis factor (TNF) inhibitor.

History of Present Illness: Ms. S., a 52-year-old teacher and mother of two, was diagnosed with RA (seropositive for rheumatoid factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) with high disease activity. After initial therapy with methotrexate 15 mg weekly over a 3-month period failed to substantially improve her joint pain and swelling, she was prescribed adalimumab 40 mg every other week. At her next 3-month evaluation, her joint pain and swelling had still not improved significantly.

Learning Objectives:

Upon successful completion of this educational activity, participants will be better able to:

  • Manage patients with RA following an inadequate response to methotrexate and a TNF inhibitor.

Overview:

Author(s)/Faculty: Gregg Silverman, MD

Source: Healio Rheumatology Education Lab

Type: Monograph

Articles/Items: 4

Release Date: 1/15/2019

Expiration Date: 1/14/2020

Credit Type: CME / ABIM MOC

Number of Credits: 0.25

Cost: Free

Provider: Vindico Medical Education

CME Information

Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.

Support Statement: There is no commercial support for this activity.

Target Audience: The intended audience for this activity is rheumatologists and other health care professionals.

Click here to view this activity.

This educational activity will utilize a case study to discuss the management of a 52-year-old patient with rheumatoid arthritis (RA) who had inadequate response to methotrexate and a tumor necrosis factor (TNF) inhibitor.

Case Presentation

Chief Complaint: Rheumatoid arthritis (RA) with worsening symptoms despite taking methotrexate and a tumor necrosis factor (TNF) inhibitor.

History of Present Illness: Ms. S., a 52-year-old teacher and mother of two, was diagnosed with RA (seropositive for rheumatoid factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) with high disease activity. After initial therapy with methotrexate 15 mg weekly over a 3-month period failed to substantially improve her joint pain and swelling, she was prescribed adalimumab 40 mg every other week. At her next 3-month evaluation, her joint pain and swelling had still not improved significantly.

Learning Objectives:

Upon successful completion of this educational activity, participants will be better able to:

  • Manage patients with RA following an inadequate response to methotrexate and a TNF inhibitor.

Overview:

Author(s)/Faculty: Gregg Silverman, MD

Source: Healio Rheumatology Education Lab

Type: Monograph

Articles/Items: 4

Release Date: 1/15/2019

Expiration Date: 1/14/2020

Credit Type: CME / ABIM MOC

Number of Credits: 0.25

Cost: Free

Provider: Vindico Medical Education

CME Information

Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.

Support Statement: There is no commercial support for this activity.

Target Audience: The intended audience for this activity is rheumatologists and other health care professionals.

Click here to view this activity.